News

Outcome Capital Expands Life Science Practice with Addition of Digital Health Industry Veterans

BOSTON, MA & RESTON, Va.–(BUSINESS WIRE)–Outcome Capital (www.outcomecapital.com) today announced that Steven Wardell and Karl Hess have joined the firm as Senior Advisors for its...

Read More
News

Outcome Capital Advises Evergreen Systems in Its Sale to Sunstone Partners

RESTON, Va.–(BUSINESS WIRE)–Outcome Capital, an advisory and investment banking firm that serves middle market growth companies in IT services, software, managed services, ADGS, healthcare and...

Read More
News

Biotech Startups: How to Succeed in a COVID-19 World

Navigating uncharted waters, biotech investors, executives and entrepreneurs are finding unique challenges (and opportunities) in a COVID-19 world. Contributing author, Outcome Capital’s Dr. Oded Ben-Joseph, Managing Director and Co-Founder of the Life Sciences Practice.

Read More
News

The Contract Waterfall: Important Financial Tool in a Federal Government Contractor’s Toolset

The Contract Waterfall: Important Financial Tool in a Federal Government Contractor’s Toolset The contract waterfall plays an important role for both the buyer and the...

Read More
News

Outcome Capital Advises Forward Photonics in its Sale

Outcome Capital Advises Forward Photonics in its Sale   April 24, 2020, Reston, VA Outcome Capital, an investment banking firm that serves middle market growth...

Read More
News

Outcome Capital Secures Growth Capital for Whisker Labs

Outcome Capital Secures Growth Capital for Whisker Labs November 26, 2019, Reston, VA Outcome Capital, an investment banking firm that serves middle market growth companies...

Read More
News

Outcome Capital and Partners HealthCare Innovation Collaborate through the Innovation Fellows Program to Provide Experience in the Business of Science

Outcome Capital and Partners HealthCare Innovation Collaborate through the Innovation Fellows Program to Provide Experience in the Business of Science June 4, 2019, Boston, MA...

Read More
News

Outcome Capital Advises Whisker Labs in the Sale of its Energy Management Business to Resideo Technologies

Outcome Capital Advises Whisker Labs in the Sale of its Energy Management Business to Resideo Technologies May 29, 2019, Reston, VA Outcome Capital, an investment...

Read More
News

Outcome Capital Announces Meridian Bioscience Has Acquired GenePOC

Outcome Capital Announces Meridian Bioscience Has Acquired GenePOC May 1, 2019, BOSTON, MA –(BUSINESS WIRE)– Outcome Capital, a specialized investment banking firm that serves middle...

Read More
News

BIO18: Pfizer’s Bourla on Volume vs. Value & a Little Dealmaking Advice from Outcome Capital

Partnerships and the move to value dominated the chatter at the BIO International Convention's 25th annual partnering meeting on Monday in the life science hub of Boston.

Read More
News

Active VCs vs. Zombies: Dysfunctional Boards That Mess With M&A

Investors want to know: Will Big Pharma go bargain hunting, do a little M&A? Will it lift my biotech portfolio out of the gutter? Multiple factors are always at work. At the most basic level, pharma still needs to acquire new products to stay afloat. Little biotechs who create things need to be acquired, or go public, to reward their investors. Those facts never change. But there’s another powerful, and dark, force creating havoc in many biotech boardrooms. People who have witnessed it don’t like to talk about it. When they do, it’s in hushed tones...

Read More
News

Outcome Capital sells operating division of East West Mortgage to Bankrate

On August 4, 2006, Outcome Capital announced that it had acted as exclusive financial advisor to East West Mortgage on the sale of three websites...

Read More

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Contact Us

  • Boston

    20 Custom House St, Suite 1200, Boston, MA 02110
    (617) 431-2278